Treatment and outcome patterns in patients with Waldenström’s Macroglobulinemia (WM): An observational, retrospective chart review across Germany

Treatment and outcome patterns in patients with Waldenström’s Macroglobulinemia (WM): An observational, retrospective chart review across Germany - WM Chart Review

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027501

Enrollment

200

Registered

2021-12-29

Start date

2022-02-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C88.0

Interventions

Group 1: Patients with first,second or third line therapy between January 1, 2016 to June 30, 2021.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients under or after treatment with a confirmed diagnosis of Waldenström’s macroglobulinaemia according to Onkopedia guidelines on WM will be included. The diagnosis should be confirmed according to guidelines valid at that time as well as risk stratification according to the International Prognostic Scoring System for WM Inclusion should be available.

Exclusion criteria

Exclusion criteria: Watch and wait patients as well as patients treated within clinical trials will not be included.

Design outcomes

Primary

Measure	Time frame
The aim of this study is to use retrospective observations of patient charts for a multicomparative analysis of different treatment lines and outcome patterns for patients with WM.	—

Secondary

Measure	Time frame
Patient Characteristica Diagnostic	—

Countries

Germany

Contacts

Public ContactChristian Buske

Universitätsklinikum Ulm

christian.buske@uni-ulm.de073150065801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026